Hepatocellular carcinoma occurrence in DAA-treated hepatitis C virus patients: Correlated or incidental? A brief review

doi:10.4254/wjh.v10.i9.595

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5495)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series.

Item

Count

PDF

360

WORD

223

HTML

2648

Figures (1-2)

306

Sum=3537

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

979

Download

979

Sum=1958

Sep 27, 2018 (publication date) through Nov 8, 2024

Times Cited of This Article

Times Cited (11)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Hepatol. Sep 27, 2018; 10(9): 595-602
Published online Sep 27, 2018. doi: 10.4254/wjh.v10.i9.595

Full Size Figure Download Figure

Figure 1 Current (March 2018) common direct antiviral agent regimes used in hepatitis C virus infection according to their target molecules in the hepatitis C virus genome.

Citation: Gigi E, Lagopoulos VI, Bekiari E. Hepatocellular carcinoma occurrence in DAA-treated hepatitis C virus patients: Correlated or incidental? A brief review. World J Hepatol 2018; 10(9): 595-602
URL: https://www.wjgnet.com/1948-5182/full/v10/i9/595.htm
DOI: https://dx.doi.org/10.4254/wjh.v10.i9.595